These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the antilipemic effect of nicotinic acid (NA) and 3-methylpyrazole-5-carboxylic acid (MPC) in rats. Tamási G; Borsy J; Patthy A Biochem Pharmacol; 1968 Sep; 17(9):1789-94. PubMed ID: 5688267 [No Abstract] [Full Text] [Related]
3. Effect of a combination of propranolol and nicotinic acid on the inhibition of norepinephrine-induced elevations of serum triglyceride, serum glycerol, and plasma free fatty acids in the dog. Lipson MJ; Naimi S; Proger S Metabolism; 1971 Jun; 20(6):580-9. PubMed ID: 5578972 [No Abstract] [Full Text] [Related]
4. New hypocholesterolemic abietamide derivatives. I. Structure-activity relationship. Fujita Y; Sempuku K; Kitaguchi K; Mori T; Murai H; Yoshikuni Y; Enomoto H; Löser R Chem Pharm Bull (Tokyo); 1980 Feb; 28(2):453-8. PubMed ID: 7389019 [No Abstract] [Full Text] [Related]
5. Effect of methoxyindole 2-carboxylic acid and 4-pentenoic acid on adipose tissue metabolism. Gorin E; Zendowski S Biochim Biophys Acta; 1975 May; 388(2):268-78. PubMed ID: 1138899 [TBL] [Abstract][Full Text] [Related]
6. The hypocholesterolemic action of eritadenine in the rat. Takashima K; Izumi K; Iwai H; Takeyama S Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648 [No Abstract] [Full Text] [Related]
7. The pharmacology of 5-(3-pyridyl)tetrazole, a hypocholesteremic lipolysis inhibitor. Pereira JN; Holland GF; Hochstein FA; Gilgore S; Defelice S; Pinson R J Pharmacol Exp Ther; 1968 Jul; 162(1):148-54. PubMed ID: 5690452 [No Abstract] [Full Text] [Related]
8. Hypocholesterolemic effect of alisol A-24-monoacetate and its related compounds in rats. Imai Y; Matsumura H; Aramaki Y Jpn J Pharmacol; 1970 Jun; 20(2):222-8. PubMed ID: 5311560 [No Abstract] [Full Text] [Related]
9. Some aspects of the effect of nicotine on plasma FFA and tissue triglycerides. Bizzi A; Tacconi MT; Medea A; Garattini S Pharmacology; 1972; 7(4):216-24. PubMed ID: 5077308 [No Abstract] [Full Text] [Related]
10. 6-Chlorochroman-2-carboxylic acids. Synthesis and biological evaluation as antagonists for cholesterol biosynthesis and lipolysis in vitro. Witiak DT; Stratford ES; Nazareth R; Wagner G; Feller DR J Med Chem; 1971 Aug; 14(8):758-66. PubMed ID: 5114072 [No Abstract] [Full Text] [Related]
11. Observations on the cholesterol-lowering mechanism of nicotinic acid and nicotinyl alcohol tartrate. Alton C; Kowalski C; Mallon J; Marschhaus C J Atheroscler Res; 1968; 8(2):265-76. PubMed ID: 5664196 [No Abstract] [Full Text] [Related]
12. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity. Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837 [TBL] [Abstract][Full Text] [Related]
13. Biological studies of AT-308. 2. Hypocholesterolemic effect of AT-308, a new derivative of 1,2,4-oxadiazole, in rats. Imai Y; Matsumura H; Tamura S; Shimamoto K Atherosclerosis; 1973; 17(1):131-7. PubMed ID: 4696739 [No Abstract] [Full Text] [Related]
14. Antilipaemic effect of nicotinamide. Dalton C Nature; 1967 Nov; 216(5117):825. PubMed ID: 4229354 [No Abstract] [Full Text] [Related]
15. Changes in serum triglyceride and cholesterol levels independently of free fatty acid after lipolysis inhibitors. Tamási G; Borsy J; Gyenge R Biochem Pharmacol; 1970 May; 19(5):1826-30. PubMed ID: 5513963 [No Abstract] [Full Text] [Related]